{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:04:24Z","timestamp":1784221464041,"version":"3.55.0"},"reference-count":25,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,6,17]]},"DOI":"10.2967\/jnumed.126.272125","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:15:22Z","timestamp":1784218522000},"page":"jnumed.126.272125","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact and Dynamics of Clonal Hematopoiesis with\n                    <sup>177<\/sup>\n                    Lu-PSMA-617 Therapy in Advanced Prostate Cancer"],"prefix":"10.2967","author":[{"given":"Praful","family":"Ravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Shu Mary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Boardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Pittard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Stoltenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jacene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachelle D.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026071609151500000_jnumed.126.272125v1.1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.annonc.2025.07.003","article-title":"Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer","volume":"36","author":"Fizazi","year":"2025","journal-title":"Ann Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026071609151500000_jnumed.126.272125v1.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268640"},{"key":"2026071609151500000_jnumed.126.272125v1.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022222"},{"key":"2026071609151500000_jnumed.126.272125v1.5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0985"},{"key":"2026071609151500000_jnumed.126.272125v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00710-0"},{"key":"2026071609151500000_jnumed.126.272125v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02858-0"},{"key":"2026071609151500000_jnumed.126.272125v1.8","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24712"},{"key":"2026071609151500000_jnumed.126.272125v1.9","doi-asserted-by":"crossref","unstructured":"Munzur AD Herberts C Kwan EM . Clonal hematopoiesis after 177Lu-PSMA-617 radioligand therapy in prostate cancer. Clin Cancer Res. 2026.","DOI":"10.1158\/1078-0432.c.8568802"},{"key":"2026071609151500000_jnumed.126.272125v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2024.03.007"},{"key":"2026071609151500000_jnumed.126.272125v1.11","first-page":"PO.20.00186","article-title":"Fitness landscape of clonal hematopoiesis under selective pressure of immune checkpoint blockade","volume":"4","author":"Miller","year":"2020","journal-title":"JCO Precis Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6712"},{"key":"2026071609151500000_jnumed.126.272125v1.13","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1158\/1078-0432.CCR-24-0803","article-title":"Clonal hematopoiesis and clinical outcomes in metastatic castration-resistant prostate cancer patients given androgen receptor pathway inhibitors (Alliance A031201)","volume":"30","author":"Jensen","year":"2024","journal-title":"Clin Cancer Res."},{"key":"2026071609151500000_jnumed.126.272125v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.07.010"},{"key":"2026071609151500000_jnumed.126.272125v1.15","doi-asserted-by":"crossref","first-page":"e17001","DOI":"10.1200\/JCO.2021.39.15_suppl.e17001","article-title":"Clonal hematopoiesis in prostate cancer inferred from somatic tumor profiling","volume":"39","author":"Marshall","year":"2021","journal-title":"J Clin Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.16","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1182\/blood-2024-206483","article-title":"Clonal hematopoiesis landscape in metastatic prostate cancer patients","volume":"144","author":"Kusne","year":"2024","journal-title":"Blood."},{"key":"2026071609151500000_jnumed.126.272125v1.17","doi-asserted-by":"crossref","first-page":"S1229","DOI":"10.1016\/j.annonc.2025.08.3034","article-title":"Clinical consequences of therapy related clonal hematopoiesis in patients treated with PSMA-targeted radionuclide therapy","volume":"36","author":"Desai","year":"2025","journal-title":"Ann Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.18","doi-asserted-by":"crossref","first-page":"e2100309","DOI":"10.1200\/PO.21.00309","article-title":"Mutant PPM1D- and TP53-driven hematopoiesis populates the hematopoietic compartment in response to peptide receptor radionuclide therapy","volume":"6","author":"Singh","year":"2022","journal-title":"JCO Precis Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid."},{"key":"2026071609151500000_jnumed.126.272125v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0081-z"},{"key":"2026071609151500000_jnumed.126.272125v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-018-0317-6"},{"key":"2026071609151500000_jnumed.126.272125v1.22","doi-asserted-by":"crossref","first-page":"TPS5131","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS5127","article-title":"PSMA-delay castration (DC): an open-label, multicenter, randomized phase 3 study of [177Lu]Lu-PSMA-617 versus observation in patients with metachronous PSMA-positive oligometastatic prostate cancer (OMPC) [abstract]","volume":"43","author":"Sartor","year":"2025","journal-title":"J Clin Oncol."},{"key":"2026071609151500000_jnumed.126.272125v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.09.101"},{"key":"2026071609151500000_jnumed.126.272125v1.24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(24)01865-8","article-title":"Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design","volume":"404","author":"Bossi","year":"2024","journal-title":"Lancet."},{"key":"2026071609151500000_jnumed.126.272125v1.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.4.433"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:15:24Z","timestamp":1784218524000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":25,"alternative-id":["10.2967\/jnumed.126.272125"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272125","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}